Literature DB >> 17000292

Different patterns of aortic wall elasticity in patients with Marfan syndrome: a noninvasive follow-up study.

Daniela Baumgartner1, Christian Baumgartner, Elisabeth Schermer, Georg Engl, Ulrich Schweigmann, Gabor Mátyás, Beat Steinmann, Jörg Ingolf Stein.   

Abstract

OBJECTIVE: Aortic complications determine the life expectancy of most patients with Marfan syndrome. To find out whether there is heterogenous aortic involvement among patients and, if there is, to characterize aortic patterns and response to long-term beta-blocker therapy, we investigated aortic elastic properties before and during beta-blocker treatment.
METHODS: In 46 patients with Marfan syndrome (age, 17.4 +/- 11.1 years) and 46 healthy control subjects, ascending and descending aortic elastic parameters were determined noninvasively before and after 39 +/- 16 months of beta-blocker treatment with atenolol.
RESULTS: Aortic diameters and distensibility distinguished Marfan patients and controls with a sensitivity of 85% and a specificity of 87%. Cluster analysis revealed 4 patterns of aortic phenotypic expression: (1) reduced ascending aortic elasticity (46% of patients), (2) diminished ascending and descending aortic elasticity (17%), (3) minimal alterations of ascending and descending aortic elasticity (20%), and (4) reduced descending aortic elasticity (17%). During follow-up, aortic elastic properties improved in 21 (70%) of 30 patients and deteriorated in 9 (30%) irrespective of beta-blocker dosage. Improvement was observed in 100% of patients (n = 7; age, 5.3 +/- 4.2 years) with end-diastolic aortic root diameters between 20 and 30 mm and in 61% of patients (14/23; age, 20.5 +/- 10.0 years) with root diameters between 30 and 52 mm.
CONCLUSIONS: Aortic elastic parameters distinguish between patients with Marfan syndrome and healthy controls and show the pattern of regional aortic involvement. Improvement or deterioration during follow-up can influence therapeutic decisions to prevent aortic dissection and rupture. Young age, small root diameter, and high distensibility are favorable prognostic factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000292     DOI: 10.1016/j.jtcvs.2006.07.001

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Can early aortic root surgery prevent further aortic dissection in Marfan syndrome?

Authors:  Hideyuki Shimizu; Hirofumi Kasahara; Atsushi Nemoto; Kentaro Yamabe; Toshihiko Ueda; Ryohei Yozu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-30

2.  Embryologic Origin Influences Smooth Muscle Cell Phenotypic Modulation Signatures in Murine Marfan Syndrome Aortic Aneurysm.

Authors:  Albert J Pedroza; Alex R Dalal; Rohan Shad; Nobu Yokoyama; Ken Nakamura; Paul Cheng; Robert C Wirka; Olivia Mitchel; Michael Baiocchi; William Hiesinger; Thomas Quertermous; Michael P Fischbein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-07-07       Impact factor: 10.514

3.  Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome.

Authors:  H H Clarice Yang; Jong Moo Kim; Elliott Chum; Cornelis van Breemen; Ada W Y Chung
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

4.  Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC Registry.

Authors:  Jonathan W Weinsaft; Richard B Devereux; Liliana R Preiss; Attila Feher; Mary J Roman; Craig T Basson; Alexi Geevarghese; William Ravekes; Harry C Dietz; Kathryn Holmes; Jennifer Habashi; Reed E Pyeritz; Joseph Bavaria; Karianna Milewski; Scott A LeMaire; Shaine Morris; Dianna M Milewicz; Siddharth Prakash; Cheryl Maslen; Howard K Song; G Michael Silberbach; Ralph V Shohet; Nazli McDonnell; Tabitha Hendershot; Kim A Eagle; Federico M Asch
Journal:  J Am Coll Cardiol       Date:  2016-06-14       Impact factor: 24.094

5.  Influence of beta-blocker therapy on aortic blood flow in patients with bicuspid aortic valve.

Authors:  Bradley D Allen; Michael Markl; Alex J Barker; Pim van Ooij; James C Carr; S Chris Malaisrie; Patrick McCarthy; Robert O Bonow; Preeti Kansal
Journal:  Int J Cardiovasc Imaging       Date:  2016-01-27       Impact factor: 2.357

6.  MRI of great vessel morphology and function in Ehlers-Danlos syndrome type IV.

Authors:  William Kerwin; Melanie Pepin; Lee Mitsumori; Vasily Yarnykh; Ulrike Schwarze; Peter Byers
Journal:  Int J Cardiovasc Imaging       Date:  2007-11-28       Impact factor: 2.357

7.  Ventricular-Vascular Coupling in Marfan and Non-Marfan Aortopathies.

Authors:  Farina Loeper; Jantine Oosterhof; Mark van den Dorpel; Denise van der Linde; Yaxin Lu; Elizabeth Robertson; Brett Hambly; Richmond Jeremy
Journal:  J Am Heart Assoc       Date:  2016-11-16       Impact factor: 5.501

8.  Quantitative proteomics reveal lineage-specific protein profiles in iPSC-derived Marfan syndrome smooth muscle cells.

Authors:  Cristiana Iosef; Albert J Pedroza; Jason Z Cui; Alex R Dalal; Mamoru Arakawa; Yasushi Tashima; Tiffany K Koyano; Grayson Burdon; Samantha M P Churovich; Joshua O Orrick; Mitchel Pariani; Michael P Fischbein
Journal:  Sci Rep       Date:  2020-11-23       Impact factor: 4.379

Review 9.  Cardiovascular magnetic resonance in Marfan syndrome.

Authors:  Helen Dormand; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2013-04-15       Impact factor: 5.364

Review 10.  Medical treatment of aortic aneurysms in Marfan syndrome and other heritable conditions.

Authors:  Christine H Attenhofer Jost; Matthias Greutmann; Heidi M Connolly; Roland Weber; Marianne Rohrbach; Angela Oxenius; Oliver Kretschmar; Thomas F Luscher; Gabor Matyas
Journal:  Curr Cardiol Rev       Date:  2014-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.